Company: OSRH
Filing Date: 2025-04-22
Form Type: 10-K
Source: 0001213900-25-034116
Chunk: 1385

Company: OSR Holdings, Inc.
Filing Date: 2025-04-22
Form: 10-K
Item: Item 6
Chunk 1385
---
2025, the date it
was adopted by the Company Board (the “Effective Date”). The Omnibus Plan will terminate automatically at 11:59PM ET on the day
before the tenth (10th) anniversary of the Effective Date unless earlier terminated by the Board or in accordance with the
terms of the Omnibus Plan.

Changes in Control 

None.

Item 13.	 Certain Relationships and Related Transactions,
and Director Independence 

On July 30, 2020, we issued an aggregate of 1,437,500 founder
shares to our Sponsor for an aggregate purchase price of $25,000 in cash, or approximately $0.017 per share. On April 25, 2022, we
executed a stock split, resulting in an aggregate of 1,725,000 founder shares held by our Sponsor (of which up to 225,000 shares were
subject to forfeiture in the event the underwriter’s Over-Allotment Option was not exercised in full). At the closing of our IPO,
our Sponsor transferred 20,000 founder shares to each of our directors and 20,000 placement warrants each to our directors who are serving
as our Chairman of the Board of Directors and the chair of our audit committee. On March 23, 2023, our Sponsor also transferred 20,000
founder shares and 20,000 placement warrants to Mr. Yoo for his service as Chief Financial Officer.

Our Sponsor purchased an aggregate of 430,000 Private Placement Units
at a price of $10.00 per unit, for an aggregate purchase price of $4,300,000, at the closing of our IPO. There will be no redemption rights
or liquidating distributions from the Trust Account with respect to the founder shares or placement shares, and the placement warrants
and placement rights will expire worthless if we not consummate a business combination on or prior to the time provided in the Company’s
Charter (as subject to extension).

On March 31, 2022, our Sponsor entered into a promissory note
with BCM Europe in the principal amount of $3,400,000 with a maturity date of December 9, 2023 (the “BCM Europe Note”).
The proceeds of the BCM Europe Note were used to fund our Sponsor’s purchase of the Private Placement Units. The BCM Europe Note
is convertible at the election of either our Sponsor or BCM Europe into (i) 310,000 Units identical to